MedTech Daily Briefing
2026-07-21
|
Section 1: MedTech Industry News
Tempus to buy cancer test-maker Personalis for $1.5B
MedTech Dive • July 20, 2026
|
Resmed ventilator safety issue linked to 5 serious injuries
MedTech Dive • July 20, 2026
|
Biotronik unveils new AI capability for spinal cord stim tech - MassDevice
MassDevice • July 20, 2026
|
GE HealthCare introduces remote access platform for imaging data - MassDevice
MassDevice • July 20, 2026
|
Jenscare has first TTVR implants in US pivotal trial - MassDevice
MassDevice • July 20, 2026
|
Medtrum to bring 300U tubeless insulin patch pump to Germany - MassDevice
MassDevice • July 20, 2026
|
Baxter warns on intravascular administration sets - MassDevice
MassDevice • July 20, 2026
|
Precision Neuroscience uses BCI to enable real-time thought-based control of computers - MassDevice
MassDevice • July 21, 2026
|
Ability Neurotech has first-in-human BCI procedure - MassDevice
MassDevice • July 21, 2026
|
Boston Scientific enrolls first patient in FARADIGM IDE trial for Faraflex PFA system - MassDevice
MassDevice • July 20, 2026
|
Medtronic to unveils AI computing platform for surgical robotics - MassDevice
MassDevice • July 21, 2026
|
Agios says adios to sickle cell program over lackluster phase 2 data
Fierce Biotech • July 21, 2026
|
Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets
Fierce Biotech • July 21, 2026
|
Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’
Fierce Biotech • July 21, 2026
|
Genetic medicine luminaries launch new center for personalized therapies
Fierce Biotech • July 20, 2026
|
‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong
Fierce Biotech • July 20, 2026
|
BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’
Fierce Biotech • July 20, 2026
|
Tempus buys out cancer genomics partner Personalis in $1.5 billion deal
Fierce Biotech • July 20, 2026
|
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
Fierce Biotech • July 20, 2026
|
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial
Fierce Biotech • July 20, 2026
|
|
Section 2: National News — MedTech Relevant
| No relevant national MedTech headlines today. |
|
Section 3: VC Press Releases
| No new VC press releases today. |
|
Section 4: Public Market Roundup — as of July 20, 2026
|
▲ Top Gainers
| TNDM |
Tandem Diabetes Care |
+5.97% |
| INSP |
Inspire Medical Systems |
+5.28% |
| BBNX |
Beta Bionics |
+3.07% |
|
|
▼ Top Losers
| KMTS |
Kestra |
-4.83% |
| XRAY |
Dentsply Sirona |
-4.20% |
| OM |
Outset Medical |
-3.33% |
|
📅 Upcoming Earnings (Next 7 Days)
| EW |
Edwards Lifesciences |
July 23, 2026 |
| PHG |
Philips |
July 28, 2026 |
|
|
MedTech Daily Briefing • Curated by automation
|
|